GB9101221D0 - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
GB9101221D0
GB9101221D0 GB919101221A GB9101221A GB9101221D0 GB 9101221 D0 GB9101221 D0 GB 9101221D0 GB 919101221 A GB919101221 A GB 919101221A GB 9101221 A GB9101221 A GB 9101221A GB 9101221 D0 GB9101221 D0 GB 9101221D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919101221A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB919101221A priority Critical patent/GB9101221D0/en
Publication of GB9101221D0 publication Critical patent/GB9101221D0/en
Priority to CA002100777A priority patent/CA2100777C/en
Priority to JP50278692A priority patent/JP3521143B2/en
Priority to EP92902664A priority patent/EP0567498A1/en
Priority to PCT/GB1992/000091 priority patent/WO1992012716A1/en
Priority to AU11641/92A priority patent/AU658169B2/en
Priority to NZ24133792A priority patent/NZ241337A/en
Priority to IE014892A priority patent/IE920148A1/en
Priority to ZA92343A priority patent/ZA92343B/en
Priority to PT100033A priority patent/PT100033B/en
Priority to MX9200214A priority patent/MX9200214A/en
Priority to KR1019930702140A priority patent/KR930702991A/en
Priority to US08/901,125 priority patent/US5929059A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB919101221A 1991-01-19 1991-01-19 Pharmaceuticals Pending GB9101221D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB919101221A GB9101221D0 (en) 1991-01-19 1991-01-19 Pharmaceuticals
CA002100777A CA2100777C (en) 1991-01-19 1992-01-16 Pharmaceutical composition containing granisetron and dexamethasone
JP50278692A JP3521143B2 (en) 1991-01-19 1992-01-16 Pharmaceutical composition containing granisetron and dexamethasone
EP92902664A EP0567498A1 (en) 1991-01-19 1992-01-16 Pharmaceutical composition containing granisetron and dexamethasone
PCT/GB1992/000091 WO1992012716A1 (en) 1991-01-19 1992-01-16 Pharmaceutical composition containing granisetron and dexamethasone
AU11641/92A AU658169B2 (en) 1991-01-19 1992-01-16 Pharmaceutical composition containing granisetron and dexamethasone
MX9200214A MX9200214A (en) 1991-01-19 1992-01-17 PHARMACEUTICAL PRODUCT INCLUDING GRANISETRON AND DEXAMETASONE.
NZ24133792A NZ241337A (en) 1991-01-19 1992-01-17 Antiemetic composition containing granisetron and dexamethasone
IE014892A IE920148A1 (en) 1991-01-19 1992-01-17 Pharmaceuticals
ZA92343A ZA92343B (en) 1991-01-19 1992-01-17 Pharmaceuticals
PT100033A PT100033B (en) 1991-01-19 1992-01-17 PHARMACEUTICAL PRODUCTS CONTAINING GRANISETRON AND DEXAMETHASONE USED IN THE TREATMENT OF NAUSEA AND VOMITING
KR1019930702140A KR930702991A (en) 1991-01-19 1993-07-16 Pharmaceutical composition containing granisetron and dexamethasone
US08/901,125 US5929059A (en) 1991-01-19 1997-07-28 Pharmaceutical compositions containing granisetron and dexamethasone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919101221A GB9101221D0 (en) 1991-01-19 1991-01-19 Pharmaceuticals

Publications (1)

Publication Number Publication Date
GB9101221D0 true GB9101221D0 (en) 1991-02-27

Family

ID=10688722

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919101221A Pending GB9101221D0 (en) 1991-01-19 1991-01-19 Pharmaceuticals

Country Status (12)

Country Link
EP (1) EP0567498A1 (en)
JP (1) JP3521143B2 (en)
KR (1) KR930702991A (en)
AU (1) AU658169B2 (en)
CA (1) CA2100777C (en)
GB (1) GB9101221D0 (en)
IE (1) IE920148A1 (en)
MX (1) MX9200214A (en)
NZ (1) NZ241337A (en)
PT (1) PT100033B (en)
WO (1) WO1992012716A1 (en)
ZA (1) ZA92343B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
WO2008103852A1 (en) * 2007-02-21 2008-08-28 Victory Pharma, Inc. Transdermal delivery of dexamethasone and promethazine
JP5537104B2 (en) * 2009-09-16 2014-07-02 テルモ株式会社 Antiemetic
KR101368587B1 (en) 2010-12-27 2014-03-05 주식회사 삼양바이오팜 Composition for prevention of nausea or vomiting
CN103222977A (en) * 2013-05-22 2013-07-31 南京工业大学 Granisetron and dexamethasone compound percutaneous controlled release patch and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687080T2 (en) * 1985-04-27 1993-03-25 Beecham Group Plc AZABICYCLONONYL INDAZOL CARBOXAMIDE WITH 5-HT ANTAGONISTIC EFFECT.
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
WO1992012716A1 (en) 1992-08-06
ZA92343B (en) 1992-12-30
AU658169B2 (en) 1995-04-06
CA2100777A1 (en) 1992-07-20
PT100033A (en) 1993-02-26
IE920148A1 (en) 1992-07-29
CA2100777C (en) 2003-08-19
AU1164192A (en) 1992-08-27
MX9200214A (en) 1992-08-01
EP0567498A1 (en) 1993-11-03
JP3521143B2 (en) 2004-04-19
NZ241337A (en) 1994-07-26
KR930702991A (en) 1993-11-29
PT100033B (en) 1999-09-30
JPH06507152A (en) 1994-08-11

Similar Documents

Publication Publication Date Title
GB9103839D0 (en) Pharmaceuticals
GB9121835D0 (en) Pharmaceuticals
GB9104656D0 (en) Pharmaceuticals
GB9101221D0 (en) Pharmaceuticals
GB9121170D0 (en) Pharmaceuticals
AP9200422A0 (en) Pharmaceuticals
ZA922702B (en) Pharmaceuticals
GB9122641D0 (en) Pharmaceuticals
GB9127184D0 (en) Pharmaceuticals
GB9110774D0 (en) Pharmaceuticals
GB9110990D0 (en) Pharmaceuticals
GB9114171D0 (en) Pharmaceuticals
GB9115125D0 (en) Pharmaceuticals
GB9116879D0 (en) Pharmaceuticals
GB9116891D0 (en) Pharmaceuticals
GB9117646D0 (en) Pharmaceuticals
GB9119449D0 (en) Pharmaceuticals
GB9119692D0 (en) Pharmaceuticals
GB9124754D0 (en) Pharmaceuticals
GB9120188D0 (en) Pharmaceuticals
GB9120390D0 (en) Pharmaceuticals
GB9102656D0 (en) Pharmaceuticals
GB9122623D0 (en) Pharmaceuticals
GB9122624D0 (en) Pharmaceuticals
GB9100580D0 (en) Pharmaceuticals